Paratek Pharmaceuticals Inc. · Boston, MA United States
| 75 Kneeland St. | Phone: 617-275-0040 |
| Boston, MA | Fax: 617-275-0039 |
| 02111 | |
| United States | 
Map This Company |
Paratek Pharmaceuticals Inc. Rankings
Company Description
Paratek Pharmaceuticals wants to teach an old drug new tricks. The company is working to create new forms of tetracycline that will be effective against newly resistant strains of bacteria and potentially treat diseases not associated with bacteria, including neurodegenerative and inflammatory conditions such as rheumatoid arthritis. It has synthesized more than 2,500 new tetracycline compounds and is sifting through each to find their possible applications. The company's Multiple Antibiotic Resistance Program (MAR) is looking at ways to genetically turn off bacteria's ability to survive, thereby preventing infection in the first place.
Paratek Pharmaceuticals Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | PrivateHeadquarters |
|---|---|
| Fiscal Year-End | December |
| Employees | 45 |
Executives
21 executives listed for Paratek Pharmaceuticals Inc.'s Boston, MA location.
| Chairman | Walter Gilbert | |
|---|---|---|
| Director | Kenneth Novack | |
| Director | Pieter Strijkert |